These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12971729)

  • 1. Metabolic response of muscle to alanine, glutamine, and valine supplementation during severe illness.
    Gore DC; Wolfe RR
    JPEN J Parenter Enteral Nutr; 2003; 27(5):307-14. PubMed ID: 12971729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine supplementation fails to affect muscle protein kinetics in critically ill patients.
    Gore DC; Wolfe RR
    JPEN J Parenter Enteral Nutr; 2002; 26(6):342-9; discussion 349-50. PubMed ID: 12405645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated glutamine synthesis in critically ill patients cannot maintain normal intramuscular free glutamine concentration.
    Mittendorfer B; Gore DC; Herndon DN; Wolfe RR
    JPEN J Parenter Enteral Nutr; 1999; 23(5):243-50; discussion 250-2. PubMed ID: 10485436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle glutamine depletion in the intensive care unit.
    Biolo G; Zorat F; Antonione R; Ciocchi B
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2169-79. PubMed ID: 16084750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of amino acid transport through interstitial fluid: assessment of four-compartment modeling for muscle protein kinetics.
    Gore DC; Wolfe RR; Chinkes DL
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E319-23. PubMed ID: 16954330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine kinetics and protein turnover in end-stage renal disease.
    Raj DS; Welbourne T; Dominic EA; Waters D; Wolfe R; Ferrando A
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E37-46. PubMed ID: 15265763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients.
    Biolo G; Iscra F; Bosutti A; Toigo G; Ciocchi B; Geatti O; Gullo A; Guarnieri G
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E323-32. PubMed ID: 10913032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamine supplementation and GH/IGF-I treatment in critically ill patients: effects on glutamine metabolism and protein balance.
    Umpleby AM; Carroll PV; Russell-Jones DL; Treacher DF; Jackson NC
    Nutrition; 2002 Feb; 18(2):127-9. PubMed ID: 11844642
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of parenteral glutamine supplementation on glucose homeostasis in critically ill polytrauma patients--A randomized-controlled clinical study.
    Grintescu IM; Luca Vasiliu I; Cucereanu Badica I; Mirea L; Pavelescu D; Balanescu A; Grintescu IC
    Clin Nutr; 2015 Jun; 34(3):377-82. PubMed ID: 24931756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of muscle glutamine formation in hypercatabolic patients.
    Biolo G; Fleming RY; Maggi SP; Nguyen TT; Herndon DN; Wolfe RR
    Clin Sci (Lond); 2000 Sep; 99(3):189-94. PubMed ID: 11787470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Glutamine Availability Exerts Different Effects on Protein and Amino Acid Metabolism in Skeletal Muscle From Healthy and Septic Rats.
    Holecek M; Sispera L; Skalska H
    JPEN J Parenter Enteral Nutr; 2015 Sep; 39(7):847-54. PubMed ID: 24906686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man.
    Nurjhan N; Bucci A; Perriello G; Stumvoll M; Dailey G; Bier DM; Toft I; Jenssen TG; Gerich JE
    J Clin Invest; 1995 Jan; 95(1):272-7. PubMed ID: 7814625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific amino acids in the critically ill patient--exogenous glutamine/arginine: a common denominator?
    Vermeulen MA; van de Poll MC; Ligthart-Melis GC; Dejong CH; van den Tol MP; Boelens PG; van Leeuwen PA
    Crit Care Med; 2007 Sep; 35(9 Suppl):S568-76. PubMed ID: 17713411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glutamine supplementation in critically ill patients.
    Wernerman J
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):155-9. PubMed ID: 18443481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the glutamine story over?
    Smedberg M; Wernerman J
    Crit Care; 2016 Nov; 20(1):361. PubMed ID: 27829456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of critically ill patients after supplementation with glutamine.
    Griffiths RD
    Nutrition; 1997; 13(7-8):752-4. PubMed ID: 9263282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation.
    Mori M; Rooyackers O; Smedberg M; Tjäder I; Norberg A; Wernerman J
    Crit Care; 2014 Apr; 18(2):R72. PubMed ID: 24731231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. l-glutamine and l-alanine supplementation increase glutamine-glutathione axis and muscle HSP-27 in rats trained using a progressive high-intensity resistance exercise.
    Leite JS; Raizel R; Hypólito TM; Rosa TD; Cruzat VF; Tirapegui J
    Appl Physiol Nutr Metab; 2016 Aug; 41(8):842-849. PubMed ID: 27447686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral and intravenously administered amino acids produce similar effects on muscle protein synthesis in the elderly.
    Rasmussen BB; Wolfe RR; Volpi E
    J Nutr Health Aging; 2002; 6(6):358-62. PubMed ID: 12459885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patients.
    Jackson NC; Carroll PV; Russell-Jones DL; Sönksen PH; Treacher DF; Umpleby AM
    Am J Physiol Endocrinol Metab; 2000 Feb; 278(2):E226-33. PubMed ID: 10662706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.